Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The federal government shutdown meant that the Securities & Exchange Commission (SEC), which oversees listing processes in ...

The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...

Radiopharmaceutical innovator AdvanCell has appointed Andrew Kay as Chair of the Board. Kay previously served as CEO of ...

In a new pharmaphorum podcast, web editor Nicole Raleigh is joined by Piet van der Graaf, Senior VP at Certara – a company ...

UK researchers have developed a platform that can test whether commercial AI algorithms developed for NHS applications are ...

A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for ...

Progress in the treatment of T-cell blood cancers – which are rare – has also been modest. So, much remains to be done to ...

Donor plasma samples contain information that could lead to massive advances in disease prevention. pharmaphorum grabbed a ...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights, following a ...

The NHS’s Online Hospital ambition signals intent. But to make it real, the focus must move from building a digital replica ...

Direct-to-Patient (DTP) platforms represent a new frontier in patient support services. Properly executed, they help more ...